Cite
HARVARD Citation
Isaacson, S. et al. (2021). Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson's Disease. Touch reviews in neurology. 17 (1), p. . [Online].